German investment bank DZ Bank has initiated coverage of Palantir Technologies (NASDAQ: PLTR) with a Buy rating and a price target of $175, the latest in a series of fresh analyst endorsements that have pushed the stock’s overall consensus to a Buy from 22 analysts, with an average 12-month target of approximately $194.77 representing more than 33 percent upside from recent trading levels around $141.
The initiation follows a week in which Palantir shares fell approximately 8 percent on Thursday after the collapse in enterprise software sentiment triggered by the ServiceNow and IBM earnings disappointments dragged the broader software sector down with it, reversing a strong Wednesday session that had seen PLTR climb 4.5 percent on the back of the company’s freshly announced $300 million contract with the US Department of Agriculture.
The USDA contract, which the department described as an AI and data analytics deployment extending across its food supply security operations, was the catalyst for Wednesday’s gain and is the latest evidence of how far Palantir’s customer base has expanded beyond its original intelligence community roots into civilian government departments that were previously considered outside the company’s natural market.
DZ Bank’s $175 target sits below the high-end of the analyst range, which reaches $260 from Citigroup, while the low-end remains at $50 from Monness Crespi Hardt, a gap so wide that it tells you more about genuine uncertainty over Palantir’s long-term valuation framework than about any disagreement on the current business momentum.
Rosenblatt Securities has the most recent and most bullish formal price target at $200, issued on March 3, representing a 41 percent premium to Thursday’s closing level and based on continued confidence in the Palantir AI Platform’s commercial penetration across both enterprise and government markets.
The commercial revenue story remains the primary growth driver, with US commercial revenue growing 137 percent year-on-year in Q4 2025, net dollar retention running at 139 percent, and total contract value bookings reaching $4.3 billion in the same period, numbers that reflect a compounding customer expansion cycle that is broadly validated across the analyst community even among those who remain neutral on the stock due to valuation concerns.
Full-year 2026 revenue guidance of $7.182 billion to $7.198 billion implies 61 percent growth, with US commercial revenue expected to exceed $3.144 billion, a projection the company’s Q1 2026 earnings due May 4 will either confirm or challenge in what is shaping up as one of the most closely watched software earnings reports of the season given the sector-wide weakness that IBM and ServiceNow’s results have injected into the macro conversation.
The valuation debate around PLTR is as old as the company’s public listing, but the terms of it have shifted meaningfully in the past 18 months: what was once primarily a debate about whether Palantir’s government contracts were durable is now primarily a debate about whether the AI platform’s commercial expansion and pricing power justify a stock that trades at approximately 230 times trailing earnings and 50 times forward sales.
Campaigners from Minneapolis drew attention this week to the Swiss National Bank’s $1.1 billion stake in Palantir, urging the SNB to divest on ethical grounds related to the company’s work with defence and intelligence clients, an ESG pressure campaign that has been a recurring feature of Palantir’s institutional investor relations without materially affecting its commercial trajectory or institutional ownership levels.
The stock’s 52-week range of $100.91 to $207.52 illustrates both the extraordinary volatility of a name that functions as a proxy for AI optimism in the government software space and the genuine difficulty of determining a fair value for a company whose TAM expansion is happening simultaneously across US commercial, US government, and international markets in ways that resist conventional discounted cash flow modelling, leaving the Barron’s case for a Buy ultimately resting on the simple observation that at current levels the market is not yet pricing in full success on any of those three vectors simultaneously.
